Джессика Сакс - Микробы хорошие и плохие. Наше здоровье и выживание в мире бактерий

21 G. Cook et al., “Direct Confocal Microscopy Studies of the Bacterial Colonization In Vitro of a Silver-Coated Heart Valve Sewing Cuff”, International Journal of Antimicrobial Agents 13 (2000), 169-73.

22 Michael Surette et al., “Quorum Sensing in Escherichia coli, Salmonella typhimurium, and Vibrio harveyi: A New Family of Genes Responsible for Autoinducer Production”, Proceedings of the National Academy of Sciences 96 (1999), 1639–1644; Stephan Schauder et al., “The luxS Family of Bacterial Autoinducers: Biosynthesis of a Novel Quorum-Sensing Signal Molecule”, Molecular Microbiology 41 (2001), 463–476.

23 Интервью, взятые автором у Бонни Басслер в ноябре – декабре 2005 г.

24 Karina Xavier, Bonnie Bassler, “Interference with AI-2-Mediated Bacterial Cell-Cell Communication”, Nature 437 (2005), 750–753.

25 E. Barth et al., “In Vitro and In Vivo Comparative Colonization of Staphylococcus aureus and Staphylococcus epidermidis on Orthopaedic Implant Materials”, Biomaterials 10 (1989), 325–328.

26 Andrea Giacometti et al., “RNA III Inhibiting Peptide Inhibits In Vivo Biofilm Formation by Drug-Resistant Staphylococcus aureus ”, Antimicrobial Agents and Chemotherapy 47 (2003), 1979–1983.

27 Garth Ehrlich et al., “Engineering Approaches for the Detection and Control of Orthopaedic Biofilm Infections”, Clinical Orthopaedics and Related Research 437 (2005), 59–66.

28 Philip Stewart, Ross Carlson, “Anti-biofilm Properties of Chitosan-Coated Surfaces”, 232nd national meeting of the American Chemical Society, poster presentation COLL 021, September 10, 2006.

29 Anneta Razatos et al., “Force Measurements Between Bacteria and Polyethylene Glycol Coated Surfaces”, Langmuir 16 (2000), 9155–9158; David Adam, “Bacteria Get the Brush Off", www.nature.com / n ews / 2000 / 001219 / full / news001221-6.html.

30 MedImmune, 2005 Annual Report, Gaithersburg, MD.

31 A. P. Simopoulos, “Omega-3 Fatty Acids in Inflammation and Autoimmune Diseases”, Journal of the American College of Nutrition 21 (2002), 495–505; F. Holguin et al., “Cardiac Autonomic Changes Associated with Fish Oil vs Soy Oi Supplmentation in the Elderly”, Chest 127 (2005), 1102–1107; A. A. Berbert et al., “Supplementation of Fish Oil and Olive Oil in Patients with Rheumatoid Arthritis”, Nutrition 21 (2005), 131–136.

32 Misha Luyer et al., “Nutritional Stimulation of Cholecystokinin Receptors Inhibits Inflammation via the Vagus Nerve”, Journal of Experimental Medicine 202 (2005), 1023–1029.

33 T. Chen et al., “Mononuclear Cell Response to Enterobacteria and Gram-positive Cell Walls of Normal Intestinal Microbiota in Early Rheumatoid Arthritis and Other Inflammatory Arthritides”, Clinical and Experimental Rheumatology 20 (2002), 193–200; Erika Isolauri,

“Probiotics in Human Disease”, American Journal of Clinical Nutrition 73 (2001), 1142S – 1146S; Kent Erickson and Neil Hubbard, “Probiotic Immunomodulation in Health and Disease”, Journal of Nutrition 130 (2000X403S – 409S.

34 K. Hatakka et al., “Effects of Probiotic Therapy on the Activity and Activation of Mild Rheumatoid Arthritis – A Pilot Study”, Scandinavian Journal of Rheumatology 32 (2003), 211–215; Ehud Baharav et al., “Lactobacillus GG Bacteria Ameliorate Arthritis in Lewis Rats”, Journal of Nutrition 134 (2004), 1964–1969; T. M. Chapman et al., “VSL#3 Probiotic Mixture: A Review of Its Use in Chronic Inflammatory Bowel Diseases”, Drugs 66 (2006), 13711387; O. Karimi et al., “Probiotics (VSL#3) in Arthralgia in Patients with Ulcerative Colitis and Crohn’s Disease: A Pilot Study”, Drugs Today 41 (2005), 453–459; Philippe Marteau et al., “Protection from Gastrointestinal Diseases with the Use of Probiotics”, American Journal of Clinical Nutrition 73 (2001), 430S – 436S.

35 Henri Braat et al., “A Phase 1 Trial with Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease”, Clinical Gastroenterology and Hepatology 4 (2006), 754–759.

36 M. Kalliomaki et al., “Probiotics in Primary Prevention of Atopic Disease: A Randomised Placebo-Controlled Trial”, Lancet 357 (2001), 1076–1079; M. Kalliomaki et al., “Probiotics and Prevention of Atopic

Disease: 4-year Follow-up of a Randomised Placebo-Controlled Trial”, Lancet 361 (2003), 1869–1871.

37 M. Viljanen, “Probiotics in the Treatment of Atopic Eczema/Dermatitis Syndrome in Infants: A Double-Blind Placebo-Controlled Trial”, Allergy 60 (2005), 494–500.

38 F. Calcinaro et al., “Oral Probiotic Administration Induces Interleukin-10 Production and Prevents Spontaneous Autoimmune Diabetes in the Non-obese Diabetic Mouse”, Diabetologia 48 (2005), 1565–1575; Mihoko Tabuchi et al., “Antidiabetic Effect of Lactobacillus GG in Streptozotocin-lnduced Diabetic Rats”, Bioscience, Biotechnology and Biochemistry 67 (2003), 1421–1424; T. Matsuzaki et al., “Prevention of Onset in an Insulin-Dependent Diabetes Mellitus Model, NOD Mice, by Oral Feeding of Lactobacillus casei”, Acta Pathologica, Microbiologica et Immunologica Scandinavica 105 (1997), 643–649; T. Matsuzaki, “Antidiabetic Effects of an Oral Administration of Lactobacillus casei in a Non-insulin-dependent Diabetes Mellitus Model Using KK-Ay Mice”, Endocrinology Journal 44 (1997), 357–365.

39 M. Ljungberg et al., “Probiotics for the Prevention of Beta Cell Autoimmunity in Children at Genetic Risk of Type 1 Diabetes – The PRODIA Study”, Annals of the New York Academy of Sciences 1079 (2006), 360–364.

40 Интервью, взятое автором у Мартина Бахманна 16 октября 2006 г.; “Cytos Biotechnology Updates on Development of Allergy Vaccine”, пресс-релиз компании от 12 июня 2006 г.; Cytos Biotechnology, 2006 Th1rd Quarter Report, September 30, 2006.

41 Cytos Biotechnology, “Vaccine Candidate CYT005-AllQbG10 for Allergic Diseases Shows Significant Efficacy in Phase 1 la Study”, пресс-релиз от 14 декабря 2005 г.; Cytos Biotechnology, “Vaccine to Treat Allergic Diseases Shows Significant Long-term Efficacy in House Dust Mite Allergy Patients”, пресс-релиз от 25 апреля 2006 г.; Cytos Biotechnology, 2006 Th1rd Quarter Report, September 30, 2006.

42 Martin Bachmann et al., “The Influence of Antigen Organization on B Cell Responsiveness”, Science 262 (1993), 1448–1451.

43 Tazio Storni et al., “Nonmethylated CG Motifs Packaged into Viruslike Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects”, Journal of Immunology 172 (2004), 1777–1785.

44 Y. Sato et al., “Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization”, Science 273 (1996), 352354; M. Roman et al., “Immunostimulatory DNA Sequences Function as T Helper-1-Promoting Adjuvants “Nature Medicine 3 (1997), 849–854.

45 David Broide et al., “Immunostimulatory DNA Sequences Inhibit IL-5, Eosinophilic Inflammation and Airway Hyperresponsiveness in Mice”, Journal of Immunology 161 (1998), 7054–7062; David Broide et al., “Systemic Administration of Immunostimulatory DNA Sequences Mediates Reversible Inhibition of TH2 Responses in a Mouse Model of Asthma”, Journal of Clinical Immunology 21 (2001), 175–182; Arash Ronaghy et al., “Immunostimulatory DNA Sequences Influence the Course of Adjuvant Arthritis”, Journal of Immunology 168 (2002), 51–56; Daniel Rachmilewitz et al., “Immunostimulatory DNA Ameliorates Experimental and Spontaneous Murine Colitis”, Gastroenterology 122 (2002), 1428–1441; Omar Duramad et al., “Inhibitors of TLR-9 Act on Multiple Cell Subsets in Mouse and Man In Vitro and Prevent Death In Vivo from Systemic Inflammation”, Journal of Immunology 174 (2004), 5193–5200; Franck Barrat et al., “Nucleic Acids of Mammalian Origin Can Act as Endogenous Ligands for Tolllike Receptors and May Promote Systemic Lupus Erythematosus”, Journal of Experimental Microbiology 202 (2005), 1131–1139.

46 Peter Creticos et al., “Immunotherapy with a Ragweed-toll-like Receptor 9 Agonist Vaccine for Allergic Rhinitis”, New England Journal of Medicine 355 (2006), 1445–1455.

1 Интервью, взятое автором у Джошуа Ледерберга, и переписка по электронной почте 4 декабря 2004 г.

Тем, кто хочет продолжить погружение в мир бактерий и в те проблемы, которые нам приходится решать, чтобы жить в этом мире, я всячески рекомендую следующие книги и статьи.

1 Hart, Tony. Microterrors. Richmond Hill, Ont.: Firefly Books, 2004. Атлас-определитель болезнетворных бактерий, вирусов, грибов и простейших, прекрасно иллюстрированный цветными микрофотографиями.

2 Levy, Stuart. The Antibiotic Paradox, 2nd ed. New York: Perseus, 2002. Переработанное и дополненное издание классической книги, которая в свое время помогла людям осознать опасность устойчивости к антибиотикам.

3 Margulis, Lynn. Symbiotic Planet. New York: Basic Books, 1998.

4 Margulis, Lynn & Sagan, Dorion. Acquiring Genomes: A Theory of the Origins of Species. New York: Basic Books, 2002. В этих двух книгах излагаются разработанная Линн Маргулис революционная теория эндосимбиоза и ее дискуссионные идеи о происхождении видов путем оптового приобретения новых наследуемых признаков.

5 Roberts, Richard et al. An Experimental Approach to Genome Annotation. Этот отчет о результатах коллоквиума Американской микробиологической академии, проходившего в июле 2004 года, имеется в сети по адресу: academy.asm.org/ images/stories/ documents/experimentalapproachgenomeannotationcolor.pdf.

6 Salyers, Abigail & Whitt, Dixie. Microbiology: Diversity, Disease, and the Environment. Bethesda, Md.: Fitzgerald Science Press, 2001. Учебник для колледжей, вполне доступный для неспециалиста, интересующегося естественными науками.

7 Salyers, Abigail & Whitt, Dixie. Revenge of the Microbes. Washington, D. C.: ASM Press, 2005. Более подробный рассказ о том, как работают те или иные антибиотики и почему они чем дальше, тем больше перестают работать.